Effects of oral paricalcitol on hyperparathyroidism and proteinuria in peritoneal dialysis patients.

Advances in peritoneal dialysis. Conference on Peritoneal Dialysis

Volumn 27, Issue , 2011, Pages 130-133

  Coronel, Francisco ^a   Rodríguez Cubillo, Beatriz ^b   Cigarrán, Secundin ^b   Gomis, Antonio ^b  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ERGOCALCIFEROL; PARATHYROID HORMONE; PARICALCITOL;

ADULT; AGED; ARTICLE; BLOOD; CHRONIC KIDNEY FAILURE; FEMALE; HUMAN; MALE; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PERITONEAL DIALYSIS; PROTEINURIA; SECONDARY HYPERPARATHYROIDISM;

ADMINISTRATION, ORAL; ADULT; AGED; ERGOCALCIFEROLS; FEMALE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PARATHYROID HORMONE; PERITONEAL DIALYSIS; PROTEINURIA;

EID: 84855451771     PISSN: 11978554     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)